Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Auckland Clinical Studies, Auckland

Universitatsspital Bern, Inselspital, Universitatsklinik fur Viszerale Chirurgie und Medizin, Hepatologie, Bern

Concorde Medical Group, PLLC, New York

Thomas Jefferson University, Philadelphia

Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia, Richmond

McGuire VA Medical Center, Richmond

Bon Secours St. Mary's Hospital of Richmond, Inc d/b/a Bon Secours Liver Institute of Virginia, Newport News

Duke University Medical Center, Duke South Clinics, Durham

Carolinas Center for Liver Disease/Carolinas HealthCare System, Durham

Atlanta Gastroenterology Associates, Atlanta

Clinical Research of South Florida, Coral Gables

Quality Medical Research, PC, Nashville

Gastro One, Germantown

Northwestern Memorial Hospital, Clinical Research Unit, Chicago

Kansas City Research Institute, Kansas City

Crescent Clinical Research Center, LLC, Metairie

Tulane University Health Sciences Center, New Orleans

The Liver Institute at Methodist Dallas Medical Center, Dallas

Texas Digestive Disease Consultants, Dallas

Texas Clinical Research Institute, Arlington

Houston Methodist Hospital, Houston

American Research Corporation at the Texas Liver Institute, San Antonio

Pinnacle Clinical Research, Live Oak

Intermountain Liver Disease and Transplant Center, Murray

Ruane Clinical Research Group Inc., Los Angeles

Cedars Sinai Medical Center, Los Angeles

Inland Empire Liver Foundation, Rialto

Swedish Organ Transplant and Liver Center, Seattle

University of Calgary, Calgary

LMC Clinical Research Inc (Bayview), Toronto

Toronto General Hospital, Toronto

Toronto Liver Center, Toronto

Toronto Digestive Disease Associates, Inc., Vaughan

Princess Margaret Hospital, Kowloon

The Chinese University of Hong Kong, Shatin

Universitatsspital Zurich, Zurich

Addenbrooke's Hospital, Cambridge